← All companies
AEMD
Aethlon Medical, Inc.
$0.67
+0.10 +16.98%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.58M
Revenue (TTM)
$574K
Net income (TTM)
-$7.15M
EPS (TTM)
$-10.61
P/E ratio
—
Dividend yield
—
Free cash flow
-$7.00M
Cash
$5.03M
Total assets
$6.33M
Gross margin
—
52-week range
$0.53 – $27.40
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Modified rights of security holders; Amended charter or bylaws
Jul 31, 2026
8-K
Entered a material agreement; Other events
Jul 8, 2026
10-K
Fiscal year ended 2026-03-31
Jun 10, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Jun 10, 2026
8-K
Other events
Jun 4, 2026
8-K
Other events
Mar 17, 2026
8-K
Director or officer change; Amended charter or bylaws; Shareholder vote results
Feb 23, 2026
10-Q
Quarter ended 2025-12-31
Feb 12, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 12, 2026
8-K
Entered a material agreement
Jan 26, 2026
8-K
Entered a material agreement; Modified rights of security holders; Regulation FD disclosure
Dec 8, 2025
10-Q
Quarter ended 2025-09-30
Nov 12, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 12, 2025
8-K
Other events
Nov 6, 2025
8-K
Delisting notice or listing-rule failure
Oct 22, 2025
8-K
Modified rights of security holders; Amended charter or bylaws
Oct 16, 2025
8-K
Other events
Sep 12, 2025
8-K
Entered a material agreement; Other events
Sep 9, 2025
8-K
Regulation FD disclosure
Aug 21, 2025
10-Q
Quarter ended 2025-06-30
Aug 13, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 13, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jun 27, 2025
10-K
Fiscal year ended 2025-03-31
Jun 26, 2025
8-K
Other events
Jun 5, 2025
8-K
Shareholder vote results
May 13, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Modified rights of security holders
Mar 17, 2025
10-Q
Quarter ended 2024-12-31
Feb 12, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 12, 2025
8-K
Delisting notice or listing-rule failure
Jan 8, 2025
8-K
Other events
Dec 20, 2024
10-Q
Quarter ended 2024-09-30
Nov 13, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 13, 2024
8-K
Other events
Nov 12, 2024
8-K
Director or officer change
Oct 3, 2024
8-K
Director or officer change; Shareholder vote results
Oct 2, 2024
8-K
Other events
Sep 19, 2024
10-K/A
Fiscal year ended 2024-03-31
Aug 15, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 14, 2024
8-K
Other events
Aug 12, 2024